IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-24467-0.html
   My bibliography  Save this article

Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity

Author

Listed:
  • Linh T. Bui

    (Translational Genomics Research Institute)

  • Nichelle I. Winters

    (Vanderbilt University Medical Center)

  • Mei-I Chung

    (Translational Genomics Research Institute)

  • Chitra Joseph

    (University of Nottingham)

  • Austin J. Gutierrez

    (Translational Genomics Research Institute)

  • Arun C. Habermann

    (Vanderbilt University Medical Center)

  • Taylor S. Adams

    (Yale School of Medicine)

  • Jonas C. Schupp

    (Yale School of Medicine)

  • Sergio Poli

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Lance M. Peter

    (Translational Genomics Research Institute)

  • Chase J. Taylor

    (Vanderbilt University Medical Center)

  • Jessica B. Blackburn

    (Vanderbilt University Medical Center)

  • Bradley W. Richmond

    (Vanderbilt University Medical Center
    Department of Veterans Affairs Medical Center)

  • Andrew G. Nicholson

    (Imperial College
    Royal Brompton and Harefield NHS Foundation Trust)

  • Doris Rassl

    (Royal Papworth Hospital NHS Foundation Trust)

  • William A. Wallace

    (Royal Infirmary of Edinburgh
    Edinburgh University Medical School)

  • Ivan O. Rosas

    (Baylor College of Medicine)

  • R. Gisli Jenkins

    (University of Nottingham)

  • Naftali Kaminski

    (Yale School of Medicine)

  • Jonathan A. Kropski

    (Vanderbilt University Medical Center
    Department of Veterans Affairs Medical Center
    Vanderbilt University)

  • Nicholas E. Banovich

    (Translational Genomics Research Institute)

Abstract

Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of 611,398 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observe a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD AT2 cells express higher levels of genes linked directly to the efficiency of viral replication and the innate immune response. Additionally, we identify basal differences in inflammatory gene expression programs that highlight how CLD alters the inflammatory microenvironment encountered upon viral exposure to the peripheral lung. Our study indicates that CLD is accompanied by changes in cell-type-specific gene expression programs that prime the lung epithelium for and influence the innate and adaptive immune responses to SARS-CoV-2 infection.

Suggested Citation

  • Linh T. Bui & Nichelle I. Winters & Mei-I Chung & Chitra Joseph & Austin J. Gutierrez & Arun C. Habermann & Taylor S. Adams & Jonas C. Schupp & Sergio Poli & Lance M. Peter & Chase J. Taylor & Jessica, 2021. "Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24467-0
    DOI: 10.1038/s41467-021-24467-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-24467-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-24467-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jaber S Alqahtani & Tope Oyelade & Abdulelah M Aldhahir & Saeed M Alghamdi & Mater Almehmadi & Abdullah S Alqahtani & Shumonta Quaderi & Swapna Mandal & John R Hurst, 2020. "Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-13, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dimitra Kale & Olga Perski & Aleksandra Herbec & Emma Beard & Lion Shahab, 2022. "Changes in Cigarette Smoking and Vaping in Response to the COVID-19 Pandemic in the UK: Findings from Baseline and 12-Month Follow up of HEBECO Study," IJERPH, MDPI, vol. 19(2), pages 1-16, January.
    2. Eugenia Lee & Stephanie Pike Moore & Erika Trapl & Craig S. Fryer & Douglas Gunzler & Kymberle L. Sterling, 2022. "Changes in Little Cigar and Cigarillo Use during the COVID-19 Pandemic: A Cross-Sectional Analysis of a Nationally Representative Sample of Young Adult Users," IJERPH, MDPI, vol. 19(15), pages 1-11, July.
    3. Aurea Lima & Hugo Sousa & Amanda Nobre & Ana Luisa Faria & Manuela Machado, 2021. "The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study," IJERPH, MDPI, vol. 18(16), pages 1-15, August.
    4. Mariaelena Gonzalez & Anna E. Epperson & Bonnie Halpern-Felsher & Deanna M. Halliday & Anna V. Song, 2021. "Smokers Are More Likely to Smoke More after the COVID-19 California Lockdown Order," IJERPH, MDPI, vol. 18(5), pages 1-9, March.
    5. Irfan, Muhammad & Akram, Waqar & James Hooper, Vincent, 2020. "What factors can help COVID-19 patients to recover quickly in Pakistan," MPRA Paper 103053, University Library of Munich, Germany, revised 15 Sep 2020.
    6. Louisa L. Y. Chan & Danielle E. Anderson & Hong Sheng Cheng & Fransiskus Xaverius Ivan & Si Chen & Adrian E. Z. Kang & Randy Foo & Akshamal M. Gamage & Pei Yee Tiew & Mariko Siyue Koh & Ken Cheah Hooi, 2022. "The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    7. Yirui Ma & Jie Deng & Qiao Liu & Min Du & Min Liu & Jue Liu, 2022. "Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis," IJERPH, MDPI, vol. 19(11), pages 1-16, June.
    8. Khurshid, Adnan & Chen, Yufeng & Rauf, Abdur & Khan, Khalid, 2023. "Critical metals in uncertainty: How Russia-Ukraine conflict drives their prices?," Resources Policy, Elsevier, vol. 85(PB).
    9. Yoo Min Park & Gregory D. Kearney & Bennett Wall & Katherine Jones & Robert J. Howard & Ray H. Hylock, 2021. "COVID-19 Deaths in the United States: Shifts in Hot Spots over the Three Phases of the Pandemic and the Spatiotemporally Varying Impact of Pandemic Vulnerability," IJERPH, MDPI, vol. 18(17), pages 1-15, August.
    10. Rhys Hamon & Miranda P. Ween, 2022. "E-Cigarette Vapour Increases ACE2 and TMPRSS2 Expression in a Flavour- and Nicotine-Dependent Manner," IJERPH, MDPI, vol. 19(22), pages 1-12, November.
    11. Romain Guignard & Guillemette Quatremère & Anne Pasquereau & Cécile Jartoux & Laure Salvaing & Guillaume Caline & François Beck & Viêt Nguyen Thanh, 2022. "Barriers Against and Motivations for Quitting Smoking during the COVID-19 Health Crisis: Results of a Qualitative Study in France," IJERPH, MDPI, vol. 19(20), pages 1-11, October.
    12. Ejin Kim & Yong Chul Kim & Jae Yoon Park & Jiyun Jung & Jung Pyo Lee & Ho Kim, 2021. "Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment," IJERPH, MDPI, vol. 18(10), pages 1-14, May.
    13. Jesus González-Rubio & Carmen Navarro-López & Elena López-Nájera & Ana López-Nájera & Lydia Jiménez-Díaz & Juan D. Navarro-López & Alberto Nájera, 2020. "A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19," IJERPH, MDPI, vol. 17(20), pages 1-16, October.
    14. Ning Zhang & Tao Xie & Wei Ning & Rongxin He & Bin Zhu & Ying Mao, 2021. "The Severity of COVID-19 and Its Determinants: A Systematic Review and Meta-Analysis in China," Sustainability, MDPI, vol. 13(9), pages 1-17, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24467-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.